SAR 31.0
(1.31%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 111.1 Million SAR | -8.47% |
2022 | 65.11 Million SAR | -17.19% |
2021 | 106.44 Million SAR | -30.53% |
2020 | 147.64 Million SAR | 1.54% |
2019 | 90.23 Million SAR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.35 Million SAR | 0.0% |
2024 Q1 | -3.35 Million SAR | -103.23% |
2023 FY | - SAR | -8.47% |
2023 Q4 | 58.57 Million SAR | 79.55% |
2023 Q3 | 32.62 Million SAR | 852.82% |
2023 Q2 | 3.42 Million SAR | 69.46% |
2023 Q1 | 2.02 Million SAR | -94.08% |
2022 Q2 | -13.54 Million SAR | -181.05% |
2022 Q1 | -4.81 Million SAR | -107.5% |
2022 FY | - SAR | -17.19% |
2022 Q4 | 34.1 Million SAR | 0.0% |
2022 Q3 | 34.1 Million SAR | 351.79% |
2021 Q1 | 7.97 Million SAR | -92.94% |
2021 FY | - SAR | -30.53% |
2021 Q4 | 64.27 Million SAR | 80.41% |
2021 Q3 | 35.62 Million SAR | 172.79% |
2021 Q2 | 13.06 Million SAR | 63.82% |
2020 Q2 | -7.09 Million SAR | -275.22% |
2020 Q1 | -1.89 Million SAR | 0.0% |
2020 FY | - SAR | 1.54% |
2020 Q4 | 112.91 Million SAR | 106.92% |
2020 Q3 | 54.56 Million SAR | 869.13% |
2019 FY | - SAR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Mouwasat Medical Services Company | 986.81 Million SAR | 88.741% |
Dallah Healthcare Company | 631.92 Million SAR | 82.418% |
National Medical Care Company | 323.02 Million SAR | 65.604% |
Al Hammadi Company For Development and Investment | 438.27 Million SAR | 74.649% |
Middle East Healthcare Company | 551.23 Million SAR | 79.844% |
Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 95.633% |
Canadian General Medical Center Complex Company | 19.92 Million SAR | -457.666% |
Future Care Trading Co. | 15.6 Million SAR | -611.851% |
Naba Alsaha Medical Services Company | 65.27 Million SAR | -70.202% |
Lana Medical Co. | 4.56 Million SAR | -2332.586% |
Al-Modawat Specialized Medical Co. | 20.76 Million SAR | -434.977% |